Trial intelligence / Profile preview

Ketamine versus magnesium sulfate gargle for prevention of postoperative sore throat after laminectomy

IRCT20210216050379N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
May 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-blind trial of ketamine and magnesium sulfate in Post-extubation sore throat (POST) (3 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Postoperative sore throat. Started May 2021; status: completed.

02

Drugs

ketaminemagnesium sulfate
03

Conditions

Post-extubation sore throat (POST)

Beyond the preview

Go deeper on IRCT20210216050379N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210216050379N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call